{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:37:42Z","timestamp":1794577062294,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405037"],"award-info":[{"award-number":["82405037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03870-5","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:27:23Z","timestamp":1764080843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Hulinyue","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AQian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxv","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"10360","key":"3870_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"10408","key":"3870_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(23)01297-7","volume":"402","author":"DJ Pinato","year":"2023","unstructured":"Pinato DJ, D\u2019Alessio A, Celsa C, Manfredi GF, Fulgenzi CAM. The price and value of therapeutic synergy in liver cancer. Lancet. 2023;402(10408):1108\u201310.","journal-title":"Lancet"},{"key":"3870_CR3","doi-asserted-by":"publisher","first-page":"121920","DOI":"10.1016\/j.biomaterials.2022.121920","volume":"292","author":"D Yao","year":"2023","unstructured":"Yao D, Wang Y, Bian K, Zhang B, Wang D. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer. Biomaterials. 2023;292:121920.","journal-title":"Biomaterials"},{"issue":"7","key":"3870_CR4","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1016\/j.apsb.2025.05.021","volume":"15","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang C, Chen Y, Wang D, Yao D. Nanomedicine-induced pyroptosis for anti-tumor immunotherapy: mechanism analysis and application prospects. Acta Pharm Sin B. 2025;15(7):3487\u2013510.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3870_CR5","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"MR Chiang","year":"2025","unstructured":"Chiang MR, Hsu CW, Pan WC, Tran NT, Lee YS, Chiang WH, et al. Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide Antigen-Captured nanosponge for remotely enhancing lung metastasis immunotherapy. ACS Nano. 2025;19(2):2117\u201335.","journal-title":"ACS Nano"},{"issue":"1","key":"3870_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS, Cheng AL, Mathurin P, Edeline J, et al. Nivolumab versus Sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2022;23(1):77\u201390.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3870_CR7","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.xcrm.2024.101505","volume":"5","author":"J Ning","year":"2024","unstructured":"Ning J, Ye Y, Shen H, Zhang R, Li H, Song T, et al. Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation. Cell Rep Med. 2024;5(5):101505.","journal-title":"Cell Rep Med"},{"issue":"79","key":"3870_CR8","doi-asserted-by":"publisher","first-page":"eabn6612","DOI":"10.1126\/sciimmunol.abn6612","volume":"8","author":"B Jneid","year":"2023","unstructured":"Jneid B, Bochnakian A, Hoffmann C, Delisle F, Djacoto E, Sirven P, et al. Selective STING stimulation in dendritic cells primes antitumor T cell responses. Sci Immunol. 2023;8(79):eabn6612.","journal-title":"Sci Immunol"},{"issue":"1","key":"3870_CR9","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1038\/s41467-025-60927-7","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Zhang H, Li S, Ren S, Huang L, Cai Z, et al. Engineering STING nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy. Nat Commun. 2025;16(1):5773.","journal-title":"Nat Commun"},{"issue":"12","key":"3870_CR10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363.","journal-title":"Nat Cancer"},{"issue":"6","key":"3870_CR11","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","volume":"122","author":"KM Garland","year":"2022","unstructured":"Garland KM, Sheehy TL, Wilson JT. Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy. Chem Rev. 2022;122(6):5977\u20136039.","journal-title":"Chem Rev"},{"key":"3870_CR12","doi-asserted-by":"publisher","first-page":"1095786","DOI":"10.3389\/fphar.2023.1095786","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Jia J, Zhu W, Chen J, Zheng Q, Li D. Therapeutic effects on cancer of the active ingredients in rhizoma Paridis. Front Pharmacol. 2023;14:1095786.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3870_CR13","doi-asserted-by":"publisher","first-page":"bio046854","DOI":"10.1242\/bio.046854","volume":"9","author":"D Pang","year":"2020","unstructured":"Pang D, Yang C, Li C, Zou Y, Feng B, Li L, et al. Polyphyllin \u2161 inhibits liver cancer cell proliferation, migration and invasion through downregulated Cofilin activity and the AKT\/NF-\u03baB pathway. Biol Open. 2020;9(2):bio046854.","journal-title":"Biol Open"},{"key":"3870_CR14","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.2147\/OTT.S287354","volume":"14","author":"B Ahmad","year":"2021","unstructured":"Ahmad B, Gamallat Y, Khan MF, Din SR, Israr M, Ahmad M, et al. Natural polyphyllins (I, II, D, VI, VII) reverses cancer through Apoptosis, Autophagy, Mitophagy, Inflammation, and necroptosis. Onco Targets Ther. 2021;14:1821\u201341.","journal-title":"Onco Targets Ther"},{"issue":"17","key":"3870_CR15","first-page":"105","volume":"30","author":"H Zhang","year":"2024","unstructured":"Zhang H, Ni J, Peng H, Zhang Y, Xu X, Li S, et al. Mechanism of polyphyllin \u2161 in induction of ferroptosis in hepatocellular carcinoma HepG2 cells. Chin J Exp Tradit Med Form. 2024;30(17):105\u201312.","journal-title":"Chin J Exp Tradit Med Form"},{"issue":"8","key":"3870_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4861","volume":"34","author":"Q Yang","year":"2020","unstructured":"Yang Q, Li H, Gui M, Li Z, Sun H. Development and validation of a rapid and sensitive LC-MS\/MS method for the determination of polyphyllin \u2161 in rat plasma and its application in a pharmacokinetic study. Biomed Chromatogr. 2020;34(8):e4861.","journal-title":"Biomed Chromatogr"},{"key":"3870_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114496","volume":"190","author":"M Ding","year":"2022","unstructured":"Ding M, Liu W, Gref R. Nanoscale MOFs: from synthesis to drug delivery and theranostics applications. Adv Drug Deliv Rev. 2022;190:114496.","journal-title":"Adv Drug Deliv Rev"},{"issue":"31","key":"3870_CR18","doi-asserted-by":"publisher","first-page":"16763","DOI":"10.1002\/anie.202102574","volume":"60","author":"P Gao","year":"2021","unstructured":"Gao P, Chen Y, Pan W, Li N, Liu Z, Tang B. Antitumor agents based on metal-organic frameworks. Angew Chem Int Ed Engl. 2021;60(31):16763\u201376.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3870_CR19","doi-asserted-by":"publisher","first-page":"1386534","DOI":"10.3389\/fbioe.2024.1386534","volume":"12","author":"Z Li","year":"2024","unstructured":"Li Z, Shao Y, Yang Y, Zan J. Zeolitic imidazolate framework-8: a versatile nanoplatform for tissue regeneration. Front Bioeng Biotechnol. 2024;12:1386534.","journal-title":"Front Bioeng Biotechnol"},{"key":"3870_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclepro.2023.139922","volume":"434","author":"C Yang","year":"2024","unstructured":"Yang C, Fang M, Zhang F, Lu Z, Zhang L. A versatile polyphenol-coordinated eco-friendly hollow ZIF-based nanohybrid for precise fungicide delivery and highly efficient suppression of Botrytis cinerea. J Clean Prod. 2024;434:139922.","journal-title":"J Clean Prod"},{"issue":"3","key":"3870_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/brv.12928","volume":"98","author":"D Boraschi","year":"2023","unstructured":"Boraschi D, Canesi L, Drobne D, Kemmerling B, Pinsino A, Prochazkova P. Interaction between nanomaterials and the innate immune system across evolution. Biol Rev Camb Philos Soc. 2023;98(3):747\u201374.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"3870_CR22","doi-asserted-by":"publisher","first-page":"1446532","DOI":"10.3389\/fimmu.2024.1446532","volume":"15","author":"C Chen","year":"2024","unstructured":"Chen C, Yuan P, Zhang Z. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects. Front Immunol. 2024;15:1446532.","journal-title":"Front Immunol"},{"issue":"8","key":"3870_CR23","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1021\/acsami.3c01176","volume":"15","author":"L Xie","year":"2023","unstructured":"Xie L, Zhang C, Liu M, Huang J, Jin X, Zhu C, et al. Nucleus-targeting manganese dioxide nanoparticles coated with the human umbilical cord mesenchymal stem cell membrane for cancer cell therapy. ACS Appl Mater Interfaces. 2023;15(8):10541\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3870_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2023.09.024","volume":"363","author":"Q Ding","year":"2023","unstructured":"Ding Q, Tang W, Li X, Ding Y, Chen X, Cao W, et al. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer. J Control Release. 2023;363:221\u201334.","journal-title":"J Control Release"},{"issue":"24","key":"3870_CR25","doi-asserted-by":"publisher","first-page":"25575","DOI":"10.1021\/acsnano.3c09734","volume":"17","author":"Q Wu","year":"2023","unstructured":"Wu Q, Tan L, Ren X, Fu C, Chen Z, Ren J, et al. Metal-organic framework-based nano-activators facilitating microwave combined therapy via a divide-and-conquer tactic for triple-negative breast cancer. ACS Nano. 2023;17(24):25575\u201390.","journal-title":"ACS Nano"},{"key":"3870_CR26","doi-asserted-by":"publisher","first-page":"122295","DOI":"10.1016\/j.biomaterials.2023.122295","volume":"302","author":"J Lei","year":"2023","unstructured":"Lei J, Zhang W, Ma L, He Y, Liang H, Zhang X, et al. Sonodynamic amplification of cGAS-STING activation by cobalt-based nanoagonist against bone and metastatic tumor. Biomaterials. 2023;302:122295.","journal-title":"Biomaterials"},{"key":"3870_CR27","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.nantod.2025.102838","volume":"65","author":"T Moorthy","year":"2025","unstructured":"Moorthy T, Chen CK, Liu ZH, Yalamandala BN, Huynh TMH, Iao HM, et al. Wireless chargeable gold yarnball-mediated mitochondrial depolarization for dendritic cell detainment in programmed brain tumor immunotherapy. Nanotoday. 2025;65:102838.","journal-title":"Nanotoday"},{"issue":"10","key":"3870_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107192","volume":"34","author":"HY Yoon","year":"2022","unstructured":"Yoon HY, Lee D, Lim DK, Koo H, Kim K. Copper-free click chemistry: applications in drug delivery, cell tracking, and tissue engineering. Adv Mater. 2022;34(10):e2107192.","journal-title":"Adv Mater"},{"key":"3870_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2022.101590","volume":"133","author":"MK Yazdi","year":"2022","unstructured":"Yazdi MK, Sajadi SM, Seidi F, Rabiee N, Fatahi Y, Rabiee M, et al. Clickable polysaccharides for biomedical applications: a comprehensive review. Prog Polym Sci. 2022;133:101590.","journal-title":"Prog Polym Sci"},{"issue":"5","key":"3870_CR30","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.apsb.2022.06.007","volume":"13","author":"H Ruan","year":"2023","unstructured":"Ruan H, Li Y, Wang C, Jiang Y, Han Y, Li Y, et al. Click chemistry extracellular vesicle\/peptide\/chemokine nanocarriers for treating central nervous system injuries. Acta Pharm Sin B. 2023;13(5):2202\u201318.","journal-title":"Acta Pharm Sin B"},{"issue":"16","key":"3870_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210895","volume":"35","author":"Y Song","year":"2023","unstructured":"Song Y, Zhang L, Wang Y, Han M, Wang Z, Wang N, et al. A bimetallic metal-organic-framework-based biomimetic nanoplatform enhances anti-leukemia immunity via synchronizing DNA demethylation and RNA hypermethylation. Adv Mater. 2023;35(16):e2210895.","journal-title":"Adv Mater"},{"issue":"1","key":"3870_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12951-024-02727-7","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Ji DK, Huang Y, Huang W, Dong X. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer. J Nanobiotechnol. 2024;22(1):461.","journal-title":"J Nanobiotechnol"},{"issue":"23","key":"3870_CR33","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1021\/acsnano.3c07885","volume":"17","author":"H Guo","year":"2023","unstructured":"Guo H, Liu Y, Li X, Wang H, Mao D, Wei L, et al. Magnetic metal-organic framework-based nanoplatform with platelet membrane coating as a synergistic programmed cell death protein 1 inhibitor against hepatocellular carcinoma. ACS Nano. 2023;17(23):23829\u201349.","journal-title":"ACS Nano"},{"key":"3870_CR34","doi-asserted-by":"publisher","first-page":"137073","DOI":"10.1016\/j.cej.2022.137073","volume":"446","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Gao Y, Tang G, Tian Y, Li Y, Wang H, et al. Facile Preparation of pH\/pectinase responsive microcapsules based on CaCO3 using fungicidal ionic liquid as a nucleating agent for sustainable disease. Chem Eng J. 2022;446:137073.","journal-title":"Chem Eng J"},{"issue":"22","key":"3870_CR35","doi-asserted-by":"publisher","first-page":"15301","DOI":"10.1021\/acs.est.1c05838","volume":"55","author":"X Zhang","year":"2021","unstructured":"Zhang X, Hu X, Wu H, Mu L. Persistence and recovery of ZIF-8 and ZIF-67 phytotoxicity. Environ Sci Technol. 2021;55(22):15301\u201312.","journal-title":"Environ Sci Technol"},{"key":"3870_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2020.126579","volume":"404","author":"Z Wu","year":"2021","unstructured":"Wu Z, Wang L, Chen S, Zhu X, Deng Q, Wang J, et al. Facile and low-temperature strategy to prepare hollow ZIF-8\/CNT polyhedrons as high-performance lithium-sulfur cathodes. Chem Eng J. 2021;404:126579.","journal-title":"Chem Eng J"},{"issue":"23","key":"3870_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1736","volume":"9","author":"X Peng","year":"2023","unstructured":"Peng X, Tang S, Tang D, Zhou D, Li Y, Chen Q, et al. Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy. Sci Adv. 2023;9(23):eadh1736.","journal-title":"Sci Adv"},{"key":"3870_CR38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2147\/JHC.S469449","volume":"11","author":"X Lv","year":"2024","unstructured":"Lv X, Lan G, Zhu L, Guo Q. Breaking the barriers of therapy resistance: harnessing ferroptosis for effective hepatocellular carcinoma therapy. J Hepatocell Carcinoma. 2024;11:1265\u201378.","journal-title":"J Hepatocell Carcinoma"},{"issue":"4","key":"3870_CR39","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/acs.jmedchem.3c01749","volume":"67","author":"TM Shi","year":"2024","unstructured":"Shi TM, Chen XF, Ti H. Ferroptosis-based therapeutic strategies toward precision medicine for cancer. J Med Chem. 2024;67(4):2238\u201363.","journal-title":"J Med Chem"},{"key":"3870_CR40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jconrel.2024.07.024","volume":"373","author":"M Yin","year":"2024","unstructured":"Yin M, Liu Z, Zhou Y, Li W, Yan J, Cao D, et al. Two-pronged anti-cancer nanovaccines enpowered by exogenous\/endogenous tumor-associated antigens. J Control Release. 2024;373:358\u201369.","journal-title":"J Control Release"},{"issue":"10","key":"3870_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tips.2023.07.007","volume":"44","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Ugalde CL, Rolland AS, Skidmore J, Devos D, Hammond TR. Therapeutic inhibition of ferroptosis in neurodegenerative disease. Trends Pharmacol Sci. 2023;44(10):674\u201388.","journal-title":"Trends Pharmacol Sci"},{"key":"3870_CR42","doi-asserted-by":"publisher","first-page":"1374182","DOI":"10.3389\/fphar.2024.1374182","volume":"15","author":"Q Liang","year":"2024","unstructured":"Liang Q, Wang Y, Li Y, Wang J, Liu C, Li Y. Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds. Front Pharmacol. 2024;15:1374182.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3870_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/antiox13060697","volume":"13","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Glandorff C, Sun M. GSH and ferroptosis: side-by-side partners in the fight against tumors. Antioxid (Basel). 2024;13(6):697.","journal-title":"Antioxid (Basel)"},{"issue":"14","key":"3870_CR44","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"key":"3870_CR45","doi-asserted-by":"publisher","first-page":"122300","DOI":"10.1016\/j.biomaterials.2023.122300","volume":"302","author":"S Guo","year":"2023","unstructured":"Guo S, Xiong W, Zhu J, Feng J, Zhou R, Fan Q, et al. A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy. Biomaterials. 2023;302:122300.","journal-title":"Biomaterials"},{"issue":"1","key":"3870_CR46","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1038\/s41467-023-38601-7","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y, Wang X, Zhang Z, Cao L, Fan X, et al. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation. Nat Commun. 2023;14(1):2950.","journal-title":"Nat Commun"},{"issue":"1","key":"3870_CR47","doi-asserted-by":"publisher","first-page":"e2304824","DOI":"10.1002\/smll.202304824","volume":"20","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Xu RH, Dai Y. Nanoghosts: harnessing mesenchymal stem cell membrane for construction of drug delivery platforms via optimized biomimetics. Small. 2024;20(1):e2304824.","journal-title":"Small"},{"issue":"4","key":"3870_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/med.22023","volume":"44","author":"M Taheri","year":"2024","unstructured":"Taheri M, Tehrani HA, Dehghani S, Alibolandi M, Arefian E, Ramezani M. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Med Res Rev. 2024;44(4):1596\u2013661.","journal-title":"Med Res Rev"},{"issue":"2","key":"3870_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/thno.90187","volume":"14","author":"A Rosu","year":"2024","unstructured":"Rosu A, Ghaemi B, Bulte JWM, Shakeri-Zadeh A. Tumor-tropic Trojan horses: using mesenchymal stem cells as cellular nanotheranostics. Theranostics. 2024;14(2):571\u201391.","journal-title":"Theranostics"},{"key":"3870_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144692","volume":"471","author":"J Li","year":"2023","unstructured":"Li J, Wang X, Guo Y, Zhang Y, Zhu A, Zeng W, et al. Ginsenoside Rg3-engineered exosomes as effective delivery platform for potentiated chemotherapy and photoimmunotherapy of glioblastoma. Chem Eng J. 2023;471:144692.","journal-title":"Chem Eng J"},{"issue":"28","key":"3870_CR51","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","volume":"18","author":"BN Yalamandala","year":"2024","unstructured":"Yalamandala BN, Chen YJ, Lin YH, Huynh TMH, Chiang WH, Chou TC, et al. A self-cascade penetrating brain tumor immunotherapy mediated by near-infrared II cell membrane-disrupting nanoflakes via detained dendritic cells. ACS Nano. 2024;18(28):18712\u201328.","journal-title":"ACS Nano"},{"issue":"4","key":"3870_CR52","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.7150\/thno.101298","volume":"15","author":"Q Du","year":"2025","unstructured":"Du Q, Ning N, Zhao X, Liu F, Zhang S, Xia Y, et al. Acylglycerol kinase inhibits macrophage anti-tumor activity via limiting MtDNA release and cGAS-STING-type I IFN response. Theranostics. 2025;15(4):1304\u201319.","journal-title":"Theranostics"},{"issue":"34","key":"3870_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202401830","volume":"34","author":"J Gao","year":"2024","unstructured":"Gao J, Wu Q, Yan Y, Chen M, Li Q, Xu Y, et al. Second near-infrared phototheranostics with cGAS-STING-activating capacity for photothermal immunotherapy. Adv Funct Mater. 2024;34(34):2401830.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"3870_CR54","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41467-025-56407-7","volume":"16","author":"K Li","year":"2025","unstructured":"Li K, Yu X, Xu Y, Wang H, Liu Z, Wu C, et al. Cascaded immunotherapy with implantable dual-drug depots sequentially releasing STING agonists and apoptosis inducers. Nat Commun. 2025;16(1):1629.","journal-title":"Nat Commun"},{"issue":"4","key":"3870_CR55","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5688","volume":"65","author":"M Yu","year":"2024","unstructured":"Yu M, Yu H, Wang H, Xu X, Sun Z, Chen W, et al. Tumor-associated macrophages activated in the tumor environment of hepatocellular carcinoma: characterization and treatment (Review). Int J Oncol. 2024;65(4):100.","journal-title":"Int J Oncol"},{"key":"3870_CR56","doi-asserted-by":"publisher","first-page":"1429812","DOI":"10.3389\/fimmu.2024.1429812","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Han G, Gu J, Chen Z, Wu J. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy. Front Immunol. 2024;15:1429812.","journal-title":"Front Immunol"},{"issue":"9","key":"3870_CR57","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","volume":"18","author":"JJ Baljon","year":"2024","unstructured":"Baljon JJ, Kwiatkowski AJ, Pagendarm HM, Stone PT, Kumar A, Bharti V, et al. A cancer nanovaccine for co-delivery of peptide neoantigens and optimized combinations of STING and TLR4 agonists. ACS Nano. 2024;18(9):6845\u201362.","journal-title":"ACS Nano"},{"issue":"26","key":"3870_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr1728","volume":"11","author":"J Zhao","year":"2025","unstructured":"Zhao J, Tong A, Liu J, Xu M, Mi P. Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion. Sci Adv. 2025;11(26):eadr1728.","journal-title":"Sci Adv"},{"issue":"27","key":"3870_CR59","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Huang PX, Wang KL, Tran NT, Iao HM, Pan WC, et al. Reprogramming immunodeficiency in lung metastases via PD-L1 SiRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation. ACS Nano. 2025;19(27):25134\u201353.","journal-title":"ACS Nano"},{"issue":"11","key":"3870_CR60","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/cac2.12605","volume":"44","author":"S Zeng","year":"2024","unstructured":"Zeng S, Hu H, Li Z, Hu Q, Shen R, Li M, et al. Local TSH\/TSHR signaling promotes CD8<Superscript>+<\/Superscript>T cell exhaustion and immune evasion in colorectal carcinoma. Cancer Commun (Lond). 2024;44(11):1287\u2013310.","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"3870_CR61","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ccell.2024.10.012","volume":"42","author":"CX Huang","year":"2024","unstructured":"Huang CX, Lao XM, Wang XY, Ren YZ, Lu YT, Shi W, et al. Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma. Cancer Cell. 2024;42(12):2082\u201397.","journal-title":"Cancer Cell"},{"issue":"8056","key":"3870_CR62","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","volume":"639","author":"Z Sethna","year":"2025","unstructured":"Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, et al. RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Nature. 2025;639(8056):1042\u201351.","journal-title":"Nature"},{"issue":"7","key":"3870_CR63","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","volume":"19","author":"AX Zhu","year":"2018","unstructured":"Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, et al. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. Lancet Oncol. 2018;19(7):940\u201352.","journal-title":"Lancet Oncol"},{"issue":"20","key":"3870_CR64","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"20","key":"3870_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413095","volume":"12","author":"J Cai","year":"2025","unstructured":"Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song L, et al. Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma. Adv Sci (Weinh). 2025;12(20):e2413095.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03870-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:02:27Z","timestamp":1767060147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03870-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3870"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03870-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Beijing University of Chinese Medicine Animal Welfare & Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"799"}}